Table 1.
Risk stratification of multiple myeloma by cytogenetic abnormalities
High risk | Intermediate risk | Standard risk |
---|---|---|
Deletion 17p | t(4;14) | t(11;14) |
t(14;16) | 1q gain | t(6;14) |
t(14;20) | Metaphase deletion 13 | All other cytogenetic abnormalities not high- or intermediate-risk |
GEP high risk signature | High plasma cell proliferative rate S-phase (≥3%) |